Putative tissue location and function of the SLC5 family member SGLT3

Experimental Physiology

Volumn 102, Issue 1, 2017, Pages 5-13

  Soták, Matúš ^a   Marks, Joanne ^b   Unwin, Robert J ^a,b,c  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; SODIUM GLUCOSE COTRANSPORTER; SODIUM GLUCOSE TRANSPORTER 3; UNCLASSIFIED DRUG; GLUCOSE; GLUCOSE TRANSPORTER 3; ISOPROTEIN; MESSENGER RNA;

GASTRIC BYPASS SURGERY; HUMAN; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; TISSUE DISTRIBUTION; ANIMAL; METABOLISM; SMALL INTESTINE;

ANIMALS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 3; HUMANS; INTESTINE, SMALL; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 85007579304     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP086042     Document Type: Review

References (29)

1. Aljure O & Díez-Sampedro A (2010). Functional characterization of mouse sodium/glucose transporter type 3b. Am J Physiol Cell Physiol 299, C58–C65.
2. Barcelona S, Menegaz D & Díez-Sampedro A (2012). Mouse SGLT3a generates proton-activated currents but does not transport sugar. Am J Physiol Cell Physiol 302, C1073–C1082.
3. Bhutta HY, Deelman TE, le Roux CW, Ashley SW, Rhoads DB & Tavakkoli A (2014). Intestinal sweet-sensing pathways and metabolic changes after Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol 307, G588–G593.
4. Bianchi L & Díez-Sampedro A (2010). A single amino acid change converts the sugar sensor SGLT3 into a sugar transporter. PLoS One 5, e10241.
5. Chen J, Williams S, Ho S, Loraine H, Hagan D, Whaley JM & Feder JN (2010). Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Ther 1, 57–92.
6. Delaere F, Duchampt A, Mounien L, Seyer P, Duraffourd C, Zitoun C, Thorens B & Mithieux G (2013). The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing. Mol Metab 2, 47–53.
7. Díez-Sampedro A, Hirayama BA, Osswald C, Gorboulev V, Baumgarten K, Volk C, Wright EM & Koepsell H (2003). A glucose sensor hiding in a family of transporters. Proc Natl Acad Sci USA 100, 11753–11758.
8. +-dependent glucose cotransporters: comparison of SGLT1 and SGLT3. J Membr Biol 176, 111–117.
9. +/glucose cotransporter. J Biol Chem 276, 49188–49194.
10. +/sugar symport. Science 321, 810–814.
11. Freeman SL, Bohan D, Darcel N & Raybould HE (2006). Luminal glucose sensing in the rat intestine has characteristics of a sodium-glucose cotransporter. Am J Physiol Gastrointest Liver Physiol 291, G439–G445.
12. Gribble FM, Williams L, Simpson AK & Reimann F (2003). A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52, 1147–1154.
13. Kothinti RK, Blodgett AB, North PE, Roman RJ & Tabatabai NM (2012). A novel SGLT is expressed in the human kidney. Eur J Pharmacol 690, 77–83.
14. Lee EY, Kaneko S, Jutabha P, Zhang X, Seino S, Jomori T, Anzai N & Miki T (2015). Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion. J Endocrinol 224, 205–214.
15. Lehmann A & Hornby PJ (2016). Intestinal SGLT1 in metabolic health and disease. Am J Physiol Gastrointest Liver Physiol 310, G887–G898.
16. Miller LJ, Malagelada JR & Go VL (1978). Postprandial duodenal function in man. Gut 19, 699–706.
17. Mithieux G, Misery P, Magnan C, Pillot B, Gautier-Stein A, Bernard C, Rajas F & Zitoun C (2005). Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab 2, 321–329.
18. Nishimura M & Naito S (2005). Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokinet 20, 452–477.
19. O'Malley D, Reimann F, Simpson AK & Gribble FM (2006). Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing. Diabetes 55, 3381–3386.
20. Pal A, Rhoads DB & Tavakkoli A (2015). Foregut exclusion disrupts intestinal glucose sensing and alters portal nutrient and hormonal milieu. Diabetes 64, 1941–1950.
21. Poulsen SB, Fenton RA & Rieg T (2015). Sodium-glucose cotransport. Curr Opin Nephrol Hypertens 24, 463–469.
22. Sala-Rabanal M, Hirayama BA, Loo DDF, Chaptal V, Abramson J & Wright EM (2012). Bridging the gap between structure and kinetics of human SGLT1. Am J Physiol Cell Physiol 302, C1293–C1305.
23. Song P, Onishi A, Koepsell H & Vallon V (2016). Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus. Expert Opin Ther Targets 20, 1109–1125.
24. Tabatabai NM, Blumenthal SS, Lewand DL & Petering DH (2001). Differential regulation of mouse kidney sodium-dependent transporters mRNA by cadmium. Toxicol Appl Pharmacol 177, 163–173.
25. Tabatabai NM, Blumenthal SS, Lewand DL & Petering DH (2003). Mouse kidney expresses mRNA of four highly related sodium-glucose cotransporters: regulation by cadmium. Kidney Int 64, 1320–1330.
26. +-d-glucose cotransporter SAAT1. Proc Natl Acad Sci USA 95, 2914–2919.
27. Vincent KM, Sharp JW & Raybould HE (2011). Intestinal glucose-induced calcium-calmodulin kinase signaling in the gut–brain axis in awake rats. Neurogastroenterol Motil 23, e282–e293.
28. Voss AA, Díez-Sampedro A, Hirayama BA, Loo DDF & Wright EM (2007). Imino sugars are potent agonists of the human glucose sensor SGLT3. Mol Pharmacol 71, 628–634.
29. Yamazaki Y, Harada S & Tokuyama S (2014). Sodium-glucose transporter type 3-mediated neuroprotective effect of acetylcholine suppresses the development of cerebral ischemic neuronal damage. Neuroscience 269, 134–142.